1. "General Medicine Services"
Formats
  1. Journal Article (305)
  2. Meeting Abstract (203)
  3. Review (20)
  4. Book Section (15)
  5. Editorial (14)
  6. Research Letter (4)
  7. Conference Paper (3)
  8. Correspondence (3)
  9. Miscellaneous (2)
  10. Guidelines (1)
Groups
  1. General Medicine Services (570)
  2. Survivorship Research (366)
  3. General Internal Medicine (311)
  4. Department of Medicine (269)
  5. Population Sciences Research Program (199)
  6. Solid Tumor Oncology Division (150)

More Groups

People
  1. Deborah Korenstein (129)
  2. Jeffrey Groeger (91)
  3. Emily Tonorezos (83)
  4. Alicia Latham (58)
  5. Zsofia Stadler (56)
  6. Kenneth Offit (47)

More People

Years
  1. 2025 (7)
  2. 2024 (23)
  3. 2023 (42)
  4. 2022 (49)
  5. 2021 (50)
  6. 2020 (66)

More Years

Publications
  1. Journal of Clinical Oncology (103)
  2. Blood (31)
  3. Journal of General Internal Medicine (25)
  4. Critical Care Medicine (24)
  5. JAMA Internal Medicine (17)
  6. Cancer (16)

More Publications

Publishers
  1. American Society of Clinical Oncology (117)
  2. Springer (59)
  3. Lippincott Williams & Wilkins (43)
  4. Elsevier Inc. (40)
  5. American Medical Association (34)
  6. American Society of Hematology (33)

More Publishers

Results (570)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer
    Journal Article

    Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019
    Journal Article

    Tiutan, T.; Wallins, J. S.; Brown, S.; Gonen, M.; Korenstein, D.
    Clinical Chemistry and Laboratory Medicine (2023)

    Fulltext@MSK | Save
  • Care at the end of life: Palliative and hospice care—Symptom management
    Book Section

    Goring, T. N.; Nelson, I. L.
    In Sydney, E.; Weinstein, E.; Rucker , L. M. (Eds.) Handbook of Outpatient Medicine. 2nd ed. (2022)

    Fulltext@MSK | Save
  • Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone +/- daratumumab induction regimen
    Meeting Abstract

    Meseha, M.; Abusamra, M.; Farooki, A.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Shah, U.; Lu, S.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker for multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • African American patients with smoldering multiple myeloma may have a lower risk of progression compared to white patients
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world single center experience
    Meeting Abstract

    Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; Maclachlan, K. H.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C.; Akhlaghi, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM patients with elevated BMI is feasible and associated with improvements in metabolic and microbiome biomarkers of progression
    Meeting Abstract

    Shah, U. A.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Tran, L.; Adintori, P. A.; Burge, M.; Funkhouser, S.; Hosszu, K.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 2 trial of colesevelam for lenalidomide-associated diarrhea
    Meeting Abstract

    Hultcrantz, M.; Hassoun, H.; Korde, N.; Mailankody, S.; Shekarkhand, T.; Burge, M.; Maclachlan, K. H.; Patel, D.; Shah, U. A.; Chung, D. J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Carfilzomib, lenalidomide and dexamethasone (KRd) vs bortezomib, lenalidomide, and dexamethasone (VRd) as induction therapy in newly diagnosed high-risk multiple myeloma
    Meeting Abstract

    Tan, C.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Patel, D.; Maclachlan, K. H.; Lahoud, O. B.; more...
    Blood (2022)

    Fulltext@MSK | Save